Dr. Hung-Yi Chen is Assistant Dean, Academic Director (Master of Finance Program) & Asst. Professor at Zhejiang University International Business School. Dr. Chen is the founding academic director of their Master of Finance programme at International Business School, Zhejiang University (QS World Rankings #45). Prior to his career at Zhejiang University, He served as Asia-Pacific Region Manager for Cambridge Centre for Alternative Finance (CCAF), Judge Business School at University of Cambridge. At CCAF, he managed FinTech research activities and expanded international outreach across Asia-Pacific countries. Dr. Chen co-authored six impactful reports published by CCAF to review FinTech development and regulation in the region.
We are the developer of an innovative technology for the production of a completely new highly effective active substance. These regenerating products are extremely effective in treatment of liver cirrhosis of various etiologies previously officially considered incurable (ascites goes away after 15 days, cirrhosis changes into fibrosis after 30-50 days, the period of complete hepatic regeneration is about 4 months). They are also effective against genital herpes virus (4-6 months), effective against hepatitis of various etiologies, including such as B, C, D ( viral load is reduced by half every 26 days, after a course of therapy, the virus is not detected in the blood, the patient ceases to be a virus carrier), drugs restore the liver in case of fatty hepatosis, pulmonary tuberculosis including MDR TB/ XDR TB (after 26 days an active form of stage 4 changes into stage 2-3 of latent form), lymphosarcoma, fibroma, myoma and pyelonephritis. The drugs prevent diabetic foot gangrene extremities. After the therapy patients no longer need previously recommended heart bypass surgery. The drug restores the function of the pancreas, and gives a complete restoration of long-term erectile dysfunction. The condition of patients with Alzheimer disease, Down's syndrome, encephalopathy, encephalitis and other diseases improves significantly without any side effects. The drugs have a strong antifibrotic effect, they dissolve scars on heart after myocardial infarction. Heart tissue completely regenerates within 6 months. This is only what we have studied so far. We have strong assumptions that our medications can also effectively affect the activity of the COVID-19 coronavirus, as well as other viruses and infections. We are interested in partners and research of our drugs.
I have broad experience of interdisciplinary work, from computing and mathematics in my PhD and post-doctoral work, to psychology, sociology, applied philosophy and communications studies in considering the social, legal and ethical impacts of computer and communications technology. I recently also starting collaborating with a film studies scholar on the impact of films and television on public perception of social issues such as security, surveillance and AI. I have published work relating to copyright, security, surveillance, privacy, responsible research and innovation, ubiquitous computing (aka Internet of Things), medical technology. I am interested in too many things.